Splash Beverage Group Rebrands as Endovia Health Sciences
Analysis based on 11 articles · First reported Aug 12, 2026 · Last updated Aug 21, 2026
The rebranding and strategic pivot to cannabinoid health sciences may attract investor interest and potentially boost the company's valuation as it aligns with a high-growth sector. However, the success depends on regulatory approvals and commercial execution, which carry inherent risks that could impact the stock's performance.
Splash Beverage Group, Inc., a company listed on the NYSE American under the ticker SBEV, announced its transformation into Usana Health Sciences, Inc., effective August 24, 2026, with a new ticker symbol EDVA. The rebranding reflects the company's strategic shift from its legacy beverage operations to a diversified cannabinoid-based health sciences platform. The new corporate identity focuses on three complementary areas: commercial pharmaceutical assets, FDA-regulated human and veterinary therapeutics, and cannabinoid-based consumer wellness and beverage products. The company has been repositioning over the past year, acquiring pharmaceutical rights, expanding international commercialization opportunities, and advancing its CannEpil product through regulated development pathways. Recently, it opened an Investigational New Animal Drug (INAD) file with the United States — Food and Drug Administration's Center for Veterinary Medicine for CannEpil, establishing a regulatory framework for its veterinary development in the United States. The name and ticker change will not affect shareholder rights, and existing stock certificates remain valid. The company aims to build a science-driven platform with differentiated intellectual property and multiple pathways to sustainable growth.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard